Atlas Trials

Recurrent Small Intestine Cancer

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Small Intestine Cancer

RecordFirmDate
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer (NCT00433550)Alliance for Clinical Trials in Oncology2007-05-01
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384)National Cancer Institute (NCI)2007-01-01
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)National Cancer Institute (NCI)2004-05-01
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681)National Cancer Institute (NCI)2001-12-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Recurrent Small Intestine Cancer automatically

Every clearance here is in the API, with alerts when new ones post.